Table 1.
Variable | Total (n=125, 100%)
|
Non-dyspnea group (n=61, 48.8%)
|
Dyspnea group (n=64, 51.2%)
|
P-value | |||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | ||
Age (years)a | 77.36 | 10.26 | 72.15 | 10.84 | 78.42 | 8.70 | <0.001d |
Body mass index | 23.07 | 3.63 | 23.24 | 3.25 | 22.91 | 3.97 | 0.62 |
CATa | 13.97 | 9.83 | 8.18 | 6.45 | 19.48 | 9.35 | <0.001d |
Exacerbation (times/last year)a | 0.64 | 0.71 | 0.48 | 0.79 | 0.80 | 0.60 | <0.001d |
Number of medications used | 2.39 | 1.16 | 2.21 | 1.08 | 2.56 | 1.22 | 0.093 |
CES-Da | 9.59 | 6.34 | 8.25 | 5.08 | 10.88 | 7.14 | 0.07 |
| |||||||
Number of subjects | % | Number of subjects | % | Number of subjects | % | ||
| |||||||
Educational attainment | 0.04c | ||||||
Middle school or below | 71 | 56.80 | 29 | 47.50 | 42 | 65.60 | |
High school or above | 54 | 43.20 | 32 | 52.50 | 22 | 34.40 | |
Monthly income (NT$) | 0.19 | ||||||
≤16,304 | 79 | 63.20 | 35 | 57.40 | 44 | 68.80 | |
≥16,305 | 46 | 36.80 | 26 | 42.60 | 20 | 31.30 | |
Smoking status | 0.48 | ||||||
Smoker | 28 | 22.40 | 12 | 19.70 | 16 | 25.00 | |
Non-smoker | 97 | 77.60 | 49 | 80.30 | 48 | 75.00 | |
Charlson Comorbidity Index | 0.98 | ||||||
1 | 91 | 72.80 | 44 | 73.33 | 47 | 73.44 | |
2 | 20 | 16.00 | 10 | 16.67 | 10 | 15.63 | |
≥3 | 13 | 10.40 | 6 | 10 | 7 | 10.94 | |
Lung function (FEV1 pred%)b | 0.01c | ||||||
Mild obstruction | 24 | 19.20 | 9 | 14.80 | 15 | 23.40 | |
Moderate obstruction | 67 | 53.60 | 41 | 67.20 | 26 | 40.60 | |
Severe or worse obstruction | 34 | 27.20 | 11 | 18.00 | 23 | 36.00 |
Notes:
Mann–Whitney U test;
Lung function was used to stratify the severity of airway obstruction according to GOLD severity definition.
P<0.05;
P<0.001.
Abbreviations: CES-D, Center for Epidemiologic Studies Depression Scale; FEV1 pred%, predicted percentage for the forced expiratory volume during the first second; CAT, chronic obstructive pulmonary disease assessment test.